Sirio Pharma Financial Flexibility Index
Sirio Pharma financial flexibility index. Sirio Pharma (300791) has a Financial Flexibility Index of 0.09x as of June 2023. Free cash flow of CN¥161.25 Million (operating CF CN¥101.61 Million minus capex CN¥59.65 Million) represents 0% of total liabilities (CN¥1.85 Billion). Explore Sirio Pharma capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Sirio Pharma (2016–2024)
Financial flexibility index of Sirio Pharma from 2016 to 2024. Historical Financial Flexibility Index trend for Sirio Pharma across 9 annual periods. Check cash flow reinvestment rate of Sirio Pharma to assess the company's total reinvestment commitment from operating cash flow.
Sirio Pharma Financial Flexibility Index by Year (2016–2024)
Sirio Pharma financial flexibility index by year from 2016 to 2024. Year-by-year free cash flow to debt coverage for Sirio Pharma. For the full cash flow conversion analysis, see 300791 cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.34x | CN¥979.10 Million | CN¥566.97 Million | CN¥2.84 Billion | ▲ +8.0% |
| 2023 | 0.32x | CN¥837.79 Million | CN¥386.08 Million | CN¥2.63 Billion | ▼ -36.0% |
| 2022 | 0.50x | CN¥738.55 Million | CN¥444.86 Million | CN¥1.48 Billion | ▼ -26.7% |
| 2021 | 0.68x | CN¥866.06 Million | CN¥341.38 Million | CN¥1.28 Billion | ▼ -41.6% |
| 2020 | 1.16x | CN¥542.72 Million | CN¥319.57 Million | CN¥466.95 Million | ▲ +20.7% |
| 2019 | 0.96x | CN¥398.50 Million | CN¥231.60 Million | CN¥414.01 Million | ▲ +72.9% |
| 2018 | 0.56x | CN¥422.78 Million | CN¥183.46 Million | CN¥759.53 Million | ▲ +88.3% |
| 2017 | 0.30x | CN¥209.18 Million | CN¥49.35 Million | CN¥707.58 Million | ▲ +1250.8% |
| 2016 | -0.03x | CN¥-25.61 Million | CN¥-98.26 Million | CN¥997.00 Million | — |